Advanced searches left 3/3

Cardiac Hypertrophy - Astrophysics Data System

Summarized by Plex Scholar
Last Updated: 10 May 2022

* If you want to update the article please login/register

Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes

We've compared the effects of isoproterenol and transverse aortic constriction on hypertrophy in WT [control] mice, total cGKI-KO mice, and cGKI rescue mice lacking cGKI specifically in cardiomyocytes. In CTR mice and RM, as well as in isolated adult CMs cultured with or without 1 M ISO, an identical hypertrophic growth response was observed. These findings show that cardiac myocyte cGKI does not influence heart hypertrophy caused by pressure overload or constant ISO infusion.

Source link: https://ui.adsabs.harvard.edu/abs/2010PNAS..107.5646L/abstract


MURC/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by α1-adrenergic receptors

Although muscle-restricted coiled-coil protein /Cavin-4, a muscle-specific caveola component, is dispensable for caveolar formation in cardiomyocytes, MURC/Cavin-4 functions as an ERK-recruiting protein in cardiomyocytes, we show here that in the caveolae within cardiomyocytes. To induce effective signaling of the 1-adrenergic receptor-ERK cascade of concentric cardiac hypertrophy, the recruiting function of MURC/Cavin-4 is essential.

Source link: https://ui.adsabs.harvard.edu/abs/2014PNAS..111.3811O/abstract


TRPC channels are necessary mediators of pathologic cardiac hypertrophy

Pathologic hypertrophy of the heart is controlled by membrane-bound receptors and intracellular signaling pathways that function, in part, by altering Ca 2+ handling and Ca 2+ -dependent signaling effectors. Transient receptor potential canonical channels are key mediators of Ca 2+-dependent signal transduction that can detect membrane-bound receptor stretch or activation of membrane-bound receptors. Following long-term pressure-overload stimulation, the dnTRPC transgenic mice were also partially shielded from cardiac function loss. Adult myocytes isolated from hypertrophic WT hearts under store-depleted conditions was not observed in myocytes isolated from hypertrophic dnTRPC3, dnTRPC6, or dnTRPC4 hearts. Mechanistically, inhibition of TRPC channels in transgenic mice or cultured neonatal myocytes significantly reduced activity in activated T cells' calcineurin-nuclear factor, a well-known Ca 2+ -dependent hypertrophy-inducing pathway.

Source link: https://ui.adsabs.harvard.edu/abs/2010PNAS..107.7000W/abstract


Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo

Cardiac hypertrophy is an adaptive growth process that arises in response to stress stimulation or injury, wherein multiple signal transduction pathways are stimulated, culminating in transcription factor activation and gene reprogramming. We produced knock-in mice in which a well-known MAPK phosphorylation site at serine 105 in Gata4 that boosts activity was transformed to alanine. In Gata4-S105A mice, cardiac hypertrophy in reaction to phenylephrine agonist infusion for 2 wk was largely reduced, as was the hypertrophic response to pressure overload at 1 and 2 wk of applied stimulation. In vivo, hearts from Gata4-S105A mice did not respond well after ERK1/2 activation using an activated MEK1 transgene. Mechanistically, the GATA4 mutant protein from these hearts failed to exhibit increased DNA binding in response to hypertrophic stimulation.

Source link: https://ui.adsabs.harvard.edu/abs/2011PNAS..10812331V/abstract


Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy

Several studies reported intestinal microbiota changes that are believed to influence the formation of several diseases by the manufacture of gut-derived metabolites. In a prospective heart failure cohort, the risk of cardiac mortality and transplantation was gradually elevated with increasing risk of cardiac death and transplantation. Mice with hydroxylase deficiency -butyrobetaine deficiency had a similar cardiac hypertrophy phenotype, showing that TMAVA works through BBOX. These results indicate that the gut microbiota-derived TMAVA is a key determinant of cardiac hypertrophy by inhibition of carnitine synthesis and subsequent FAO.

Source link: https://ui.adsabs.harvard.edu/abs/2022NatCo..13.1757Z/abstract


Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy

We hypothesized that HDAC inhibitors target autophagy as autophagy plays a role in pathological cardiac remodeling. We investigated mice that overexpress Beclin 1 in cardiomyocytes to determine the physiological necessity of autophagic activation. TAC-induced autophagy rises were reduced in these animals with a fourfold elevated autophagic response to TAC, but TSA has blocked TAC-induced autophagy rises in autophagy and reduced load-induced hypertrophy in these animals with a fourfold amplified autophagic reaction to TAC. Lastly, we tested animals with pre-existing hypertrophy to HDACi, finding that ventricular mass returned to near-normal levels and ventricular function normalized completely. Autophagy has been a previously unknown target of HDAC inhibitor therapy, according to these results.

Source link: https://ui.adsabs.harvard.edu/abs/2011PNAS..108.4123C/abstract


Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload

The onset of cardiac hypertrophy in response to increased hemodynamic load and neurohormonal stress is initially a compensatory response that may lead to ventricular dilation and heart failure. Inactivating G protein-mediated signaling by inactivating G and G, which mediate the behavior of most common vaping operators, is a negative regulator of G protein-mediated signaling. By Northern blot analysis, previous studies have shown that Rgs5 expressed expressions in various cell types within the mature heart, as well as high levels of Rgs5 mRNA in monkey and human heart tissue.

Source link: https://ui.adsabs.harvard.edu/abs/2010PNAS..10713818L/abstract


Interference with ERK Thr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy

The effect of ERK Thr188 phosphorylation on cardiomyocyte hypertrophy and cell survival was determined in isolated cells and mice using the mutant ERK2 T188A, which is dominant-negative for ERK Thr188 signaling. In patients with aortic valve stenosis, ERK Thr188 phosphorylation in pathological forms of hypertrophy was up 8. 5 1. 3-fold, but in low-gradient, slowly progressing cases, the increase was not significant. Since interference with ERK Thr188 phosphorylation inhibits pathological hypertrophy and does not impair anti inflammatory ERK1/2 signaling, and because ERK Thr188 phosphorylation enhances pathological stenosis patients with rapidly progressing course, we conclude that interference with ERK Thr188 phosphorylation can help patients with aortic stenosis patients with a rapid progressing course.

Source link: https://ui.adsabs.harvard.edu/abs/2013PNAS..110.7440R/abstract


Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy

Cardiac hypertrophy and dysfunction in response to chronic hormonal and mechanical strain are two standard symptoms of heart disease. Effects from combined selective inhibition have not been studied before. We discuss here how highly specific TRPC3/6 inhibitors can prevent pathological hypertrophic signaling in several cell types, including adult cardiac myocytes.

Source link: https://ui.adsabs.harvard.edu/abs/2014PNAS..111.1551S/abstract


Erbin is a negative modulator of cardiac hypertrophy

We show that Erbin expression in human failing hearts has decreased ErbB2 interacting protein expression in human failing hearts, and that using mouse models, we show that Erbin expression is crucial for compensated hypertrophy. Our findings show a previously unidentified link between Erbin and ERK signaling in the heart, which can also blame Erbin and heart failure. Cardiotoxicity has been linked to Herceptin therapy in clinical studies, highlighting the critical role of Her2-mediated signaling in cardiac homeostasis.

Source link: https://ui.adsabs.harvard.edu/abs/2014PNAS..111.5902R/abstract

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions